CN102430040A - Medicine for treating diabetes - Google Patents
Medicine for treating diabetes Download PDFInfo
- Publication number
- CN102430040A CN102430040A CN2011104543840A CN201110454384A CN102430040A CN 102430040 A CN102430040 A CN 102430040A CN 2011104543840 A CN2011104543840 A CN 2011104543840A CN 201110454384 A CN201110454384 A CN 201110454384A CN 102430040 A CN102430040 A CN 102430040A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- diabetes
- treating diabetes
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 15
- 229940079593 drug Drugs 0.000 title claims description 10
- 239000009636 Huang Qi Substances 0.000 claims abstract description 6
- 239000002552 dosage form Substances 0.000 claims abstract description 6
- 210000003038 endothelium Anatomy 0.000 claims abstract description 6
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 239000007924 injection Substances 0.000 claims abstract description 4
- 238000002347 injection Methods 0.000 claims abstract description 4
- 239000002671 adjuvant Substances 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims abstract description 3
- 239000006187 pill Substances 0.000 claims abstract description 3
- 239000003826 tablet Substances 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 9
- 239000008517 radix Trichosanthis Substances 0.000 claims description 5
- 241000605447 Anemarrhena Species 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 10
- 210000001124 body fluid Anatomy 0.000 abstract description 7
- 239000010839 body fluid Substances 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 210000002784 stomach Anatomy 0.000 abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 238000010791 quenching Methods 0.000 abstract description 5
- 230000035922 thirst Effects 0.000 abstract description 5
- 210000000952 spleen Anatomy 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 238000007796 conventional method Methods 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 238000004140 cleaning Methods 0.000 abstract 1
- -1 decoction Substances 0.000 abstract 1
- 230000000225 effect on diabetes Effects 0.000 abstract 1
- 230000000171 quenching effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
- 229960003105 metformin Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 208000022306 Cerebral injury Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229960004580 glibenclamide Drugs 0.000 description 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000007410 oral glucose tolerance test Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A medicine for treating diabetes is prepared by selecting rhizoma Dioscoreae, radix astragali, rhizoma anemarrhenae, endothelium corneum Gigeriae Galli, radix Puerariae, Trichosanthis radix, Corni fructus, and radix Adenophorae, cleaning with clear water, mixing, adding conventional adjuvants, and making into pharmaceutically acceptable dosage forms such as decoction, tablet, capsule, pill, oral liquid, injection, etc. by conventional method. The medicine has the effects of invigorating primordial qi, nourishing kidney yin, strengthening spleen and stomach, promoting the production of body fluid and quenching thirst, has good treatment effect on diabetes and has no toxic or side effect.
Description
Technical field
The present invention relates to a kind of medicine of treating diabetes, especially relating to a kind of is the medicine of the treatment diabetes of crude drug preparation with Chinese medicine.
Background technology
Diabetes are to act on that body causes hypoinsulinism, insulin resistant etc. and a series of metabolism disorder syndromes such as the sugar that causes, protein, fat, power and water Xie Zhi by inherited genetic factors, immunologic function disorder, infected by microbes and toxin thereof, free radical toxin, Nervous and Mental Factors or the like various virulence factors; Be a kind of common pilosity, the disease that is difficult to effect a radical cure.Be main feature with the hyperglycemia clinically, and polyuria, polydipsia, polyphagia appear, performance such as become thin, i.e. " three-many-one-little " symptom, most of patients does not have uncomfortable symptom in early days; The blood glucose long time is higher during prescription on individual diagnosis, and different degrees of complications, like retinopathy, and the foot pathological changes; Diabetes and hypertension, cerebral infarction or injury of kidney are because modern life rhythm is accelerated; The obvious rejuvenation of falling ill, its body etiology unknown, but sickness rate obviously rises.
Now treatment of diabetes is mainly realized through the Western medicine blood sugar control, like oral administration of metformin and glibenclamide, insulin injection etc., but this type of Therapeutic Method has side effect or treatment inconvenience more, is not ideal Therapeutic Method.
Summary of the invention
The purpose of this invention is to provide a kind of is the medicine of the treatment diabetes of crude drug preparation with Chinese medicine, and this medicine is the principle treatment to rise vigour, nourishing kidney-yin, strengthening the spleen and stomach, promoting the production of body fluid to quench thirst, and therapeutic effect is good, and expense is low.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Rhizoma Dioscoreae 24～36 Radix Astragali 12～18 Rhizoma Anemarrhenaes 12～18
Endothelium Corneum Gigeriae Galli 4～8 Radix Puerariaes 4～6 Radix Trichosanthis 8～12
Fructus Corni 12～18 Radix Adenophorae (Radix Glehniae) 12～18.
Get the above-mentioned raw materials medicine, add conventional adjuvant, according to common process; Process various dosage forms such as pharmaceutically acceptable decoction, tablet, capsule, pill, oral liquid, injection, wherein said common process can be a water extraction, decocte with water 2-3 time; Amount of water is a conventional amount used, merges aqueous extract, the ethanol concentrate drying; According to common process, process various dosage forms; Also can process various dosage forms by other conventional method extractions, purification, vacuum drying.
The preferred dosage form of the present invention is a powder.
The concrete method for preparing of drug powder of the present invention is: said medicine by said parts by weight mix homogeneously, is ground into 100～120 purpose medicated powder, and sterilization makes the powder product.
In the prescription of the present invention, Rhizoma Dioscoreae is strengthened the spleen and stomach, the tonifying the lung tonifying YIN; The Radix Astragali tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration; Rhizoma Anemarrhenae promoting the production of body fluid to quench thirst is nourshing Yin and drynsessmoistening prescription; The Endothelium Corneum Gigeriae Galli invigorating the stomach and promoting digestion; The Radix Puerariae promoting the production of body fluid to quench thirst; The Radix Trichosanthis clearing away heat and promoting production of body fluid; The Fructus Corni liver and kidney tonifying, convergence solid three is born; Radix Adenophorae (Radix Glehniae) nourishing the stomach to promote the production of body fluid, all medicines share, and can play the effect that rises vigour, nourishing kidney-yin, strengthening the spleen and stomach, promoting the production of body fluid to quench thirst, and are remarkable to the treatment diabetes curative effect, and cheap.
For further investigating the clinical efficacy of drug treatment of diabetic of the present invention, select 63 routine diabeticss to carry out clinical observation on the therapeutic effect.
63 routine diabeticss are divided into 2 groups, and 30 people are organized in treatment, matched group 33 people, and all case diagnosis meet the diabetes diagnosis standard of WHO formulation in 1999; Clinical symptoms ten is venous plasma blood glucose >=11.0mmol/L immediately, or empty stomach venous plasma blood glucose >=7.0mmol/L, or 2 hours venous plasma blood glucose >=11.0mmol/L of oral glucose tolerance test.
Therapeutic Method: the treatment group is taken powder agent medicine of the present invention, every day 1 time, each 10g; The matched group oral administration of metformin, once-a-day, each 0.5g.
Before and after the treatment, treatment group and each parameter of the matched group patient chamber of experimentizing inspection, see table 1:
The variation of each parameter before and after table 1 diabetic therapy
Criterion of therapeutical effect: formulate with reference to State Administration of Traditional Chinese Medicine's " traditional Chinese medical science disease diagnosis criterion of therapeutical effect " />.Produce effects: symptom, sign disappear, and < 7.2mmol/>L, < 8.3mmol/>L, twenty-four-hour urine sugar is < 10.0g quantitatively for 2 hours after the meal blood glucose for fasting glucose.Effectively: treatment back symptom is obviously improved, and < 8.3mmol/>L, < 10mmolL, twenty-four-hour urine sugar is < 25.0g quantitatively for 2 hours after the meal blood glucose for fasting glucose.Invalid: treatment back symptom does not have obvious improvement, and blood glucose, glucose in urine descend and do not reach above-mentioned standard.
Two groups of case treatment back curative effect comparative results are seen table 2.
Table 2 liang group case treatment back curative effect relatively.
| Group | The example number | Produce effects n (%) | Effective n (%) | Invalid n (%) | Total effective rate n (%) |
| Matched group | 33 | 11（33.3） | 14（42.5） | ?8（24.2） | 25（75.8） |
| The treatment group | 30 | 20（66.7） | 6（20） | 4（13.3） | 26（86.7） |
The specific embodiment
Embodiment 1
Get Rhizoma Dioscoreae 240g, Radix Astragali 120g, Rhizoma Anemarrhenae 120g, Endothelium Corneum Gigeriae Galli 40g, Radix Puerariae 40g, Radix Trichosanthis 80g, Fructus Corni 120g, Radix Adenophorae (Radix Glehniae) 180g mix homogeneously selected, that clear water is cleaned, be ground into 100～120 medicated powder, sterilization makes the powder product.
Embodiment 2
Get Rhizoma Dioscoreae 360g, Radix Astragali 180g, Rhizoma Anemarrhenae 180g, Endothelium Corneum Gigeriae Galli 80g, Radix Puerariae 60g, Radix Trichosanthis 120g, Fructus Corni 180g, Radix Adenophorae (Radix Glehniae) 180g mix homogeneously selected, that clear water is cleaned; Be ground into 100～120 medicated powder; Sterilization in incapsulating by conventional method, is processed capsule.
Claims (2)
1. medicine of treating diabetes is that crude drug prepares by the Chinese medicine of following portions by weight:
Rhizoma Dioscoreae 24～36 Radix Astragali 12～18 Rhizoma Anemarrhenaes 12～18
Endothelium Corneum Gigeriae Galli 4～8 Radix Puerariaes 4～6 Radix Trichosanthis 8～12
Fructus Corni 12～18 Radix Adenophorae (Radix Glehniae) 12～18.
2. the medicine of treatment diabetes according to claim 1; It is characterized in that getting the above-mentioned raw materials medicine; Add conventional adjuvant,, process various dosage forms such as pharmaceutically acceptable decoction, tablet, capsule, pill, oral liquid, injection according to common process.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104543840A CN102430040A (en) | 2011-12-30 | 2011-12-30 | Medicine for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104543840A CN102430040A (en) | 2011-12-30 | 2011-12-30 | Medicine for treating diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102430040A true CN102430040A (en) | 2012-05-02 |
Family
ID=45978625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104543840A Pending CN102430040A (en) | 2011-12-30 | 2011-12-30 | Medicine for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102430040A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108042684A (en) * | 2018-01-25 | 2018-05-18 | 王茂全 | A kind of Chinese medicine composition for treating diabetes B and preparation method thereof |
| CN111195326A (en) * | 2018-11-19 | 2020-05-26 | 安顺玉龙医院 | Preparation method of blood sugar-reducing and thirst-quenching powder |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101125173A (en) * | 2007-09-07 | 2008-02-20 | 王慧林 | Traditional Chinese medicine 'guiyuantangkang' for treating diabetes and its complication |
| CN101138369A (en) * | 2006-09-06 | 2008-03-12 | 蔡如桂 | Thirst-eliminating tea |
| CN101491629A (en) * | 2008-01-21 | 2009-07-29 | 北京晨钟荣福科技有限公司 | Medicine composition for treating diabetes and preparation method thereof |
| CN101947284A (en) * | 2010-09-19 | 2011-01-19 | 蔡伦 | Traditional Chinese medicinal composition for treating diabetes and preparation method thereof |
| CN102145120A (en) * | 2011-03-31 | 2011-08-10 | 山东大学 | A kind of traditional Chinese medicine composition suitable for preparing and treating type II diabetes |
-
2011
- 2011-12-30 CN CN2011104543840A patent/CN102430040A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101138369A (en) * | 2006-09-06 | 2008-03-12 | 蔡如桂 | Thirst-eliminating tea |
| CN101125173A (en) * | 2007-09-07 | 2008-02-20 | 王慧林 | Traditional Chinese medicine 'guiyuantangkang' for treating diabetes and its complication |
| CN101491629A (en) * | 2008-01-21 | 2009-07-29 | 北京晨钟荣福科技有限公司 | Medicine composition for treating diabetes and preparation method thereof |
| CN101947284A (en) * | 2010-09-19 | 2011-01-19 | 蔡伦 | Traditional Chinese medicinal composition for treating diabetes and preparation method thereof |
| CN102145120A (en) * | 2011-03-31 | 2011-08-10 | 山东大学 | A kind of traditional Chinese medicine composition suitable for preparing and treating type II diabetes |
Non-Patent Citations (3)
| Title |
|---|
| 《四川中医》 19830315 樊学成等 加味玉液汤治疗消渴证 , 第03期 * |
| 张锡纯（清） 原著: "《医学衷中参西录》", 31 January 2007, article "【玉液汤】" * |
| 樊学成等: "加味玉液汤治疗消渴证", 《四川中医》, no. 03, 15 March 1983 (1983-03-15) * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108042684A (en) * | 2018-01-25 | 2018-05-18 | 王茂全 | A kind of Chinese medicine composition for treating diabetes B and preparation method thereof |
| CN111195326A (en) * | 2018-11-19 | 2020-05-26 | 安顺玉龙医院 | Preparation method of blood sugar-reducing and thirst-quenching powder |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN102631595A (en) | Medicament for treating II-type diabetes mellitus and preparation method thereof | |
| CN102488830B (en) | Pharmaceutical composition for lowering blood sugar | |
| CN102091268A (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
| CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN1367003A (en) | Medicine for curing AIDS | |
| CN102940800A (en) | Traditional Chinese medicine for treating diabetes | |
| CN102430040A (en) | Medicine for treating diabetes | |
| CN103169868B (en) | A kind of oral medicine Radix Astragali diabetes capsule for the treatment of diabetes and preparation method thereof | |
| CN112336802B (en) | Traditional Chinese medicine composition for improving glycolipidosis metabolism of diabetes and application thereof | |
| CN101773620B (en) | Heat-clearing stranguria-treating drug | |
| CN101112504B (en) | Chinese medicine for curing cancer and the method for preparing the oral liquid thereof | |
| CN100577199C (en) | Application of Xiangsha Yangwei Pill | |
| CN116726083B (en) | Traditional Chinese medicine composition for treating chronic prostatitis | |
| CN103446410B (en) | Traditional Chinese medicine preparation for treating viral myocarditis | |
| CN102225155A (en) | A kind of pharmaceutical composition for treating pulmonary fibrosis | |
| CN102784344B (en) | Traditional Chinese medicine preparation for treating pulmonary tuberculosis | |
| CN1990033A (en) | Drug for treating hypertension, dense blood and arteriosclerosis | |
| CN117379527A (en) | Traditional Chinese medicine composition for pregnancy reaction | |
| CN1318042C (en) | Application of barbat skullcap in preparing medication for treating diabetes | |
| CN104958530A (en) | Traditional Chinese medicinal composition for treating infantile pneumonia | |
| CN105288107A (en) | Compound hippophae rhamnoides composition for clearing heat from throat and preparation method thereof | |
| CN114533838A (en) | Traditional Chinese medicine for strengthening body resistance and eliminating evil to treat early and middle lung cancer | |
| CN104623282A (en) | Traditional Chinese medicine healthy preparation for conditioning hypertension | |
| CN103316258B (en) | Medicine composition for treating infantile vaginitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120502 |